Detalles de la búsqueda
1.
Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.
Ann Oncol;
34(12): 1152-1164, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797734
2.
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancer.
Eur J Nucl Med Mol Imaging;
47(5): 1252-1260, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31915897
3.
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.
Ann Oncol;
27(9): 1733-9, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27287207
4.
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy.
Ann Oncol;
31(6): 823-825, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171750
5.
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).
Ann Oncol;
24(11): 2732-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857961
6.
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
Ann Oncol;
24(4): 1099-104, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23139262
7.
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO).
Ann Oncol;
23(2): 346-52, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21562072
8.
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.
Ann Oncol;
23(5): 1185-1189, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976386
9.
Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Gynecol Oncol;
121(2): 258-63, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21295334
10.
Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial.
Gynecol Oncol;
117(2): 276-80, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20226502
11.
[Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups]. / Prise en charge des tumeurs primitives et métastatiques du péritoine en période de pandémie CoViD-19. Pistes de réflexion et de priorisation du groupe RENAPE et BIG-RENAPE.
J Chir Visc;
157(3): S25-S32, 2020 Jun.
Artículo
en Francés
| MEDLINE | ID: mdl-32328206
12.
Treatment of primary and metastatic peritoneal tumors in the Covid-19 pandemic. Proposals for prioritization from the RENAPE and BIG-RENAPE groups.
J Visc Surg;
157(3S1): S25-S31, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32387058
13.
[Malignant epithelial ovarian cancer: Role of intra peritoneal chemotherapy and hyperthermic intra peritoneal chemotherapy (HIPEC): Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]. / Tumeurs épithéliales malignes de l'ovaire : place de la chimiothérapie intrapéritonéale et de la chimiothérapie hyperthermique intrapéritonéale (CHIP). Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire ¼ élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l'égide du CNGOF et labellisée par l'INCa.
Gynecol Obstet Fertil Senol;
47(2): 214-221, 2019 02.
Artículo
en Francés
| MEDLINE | ID: mdl-30712963
14.
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up).
J Gynecol Obstet Hum Reprod;
48(6): 379-386, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936025
15.
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.
J Gynecol Obstet Hum Reprod;
48(6): 369-378, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30936027
16.
[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)]. / Partie 2 rédigée à partir de la synthèse de la recommandation nationale de bonnes pratiques cliniques intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire ¼ élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l'INCa. (Traitement systémique et intrapéritonéal, personnes âgées, préservation de la fertilité et suivi).
Gynecol Obstet Fertil Senol;
47(2): 111-119, 2019 02.
Artículo
en Francés
| MEDLINE | ID: mdl-30704955
17.
[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)]. / Partie 1 rédigée sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d'un cancer épithélial de l'ovaire ¼ élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY et labélisée par l'INCa. (Explorations diagnostiques et bilan d'extension, chirurgie, soins périopératoires et anatomopathologie).
Gynecol Obstet Fertil Senol;
47(2): 100-110, 2019 02.
Artículo
en Francés
| MEDLINE | ID: mdl-30686724
18.
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
Eur J Obstet Gynecol Reprod Biol;
236: 214-223, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30905627
19.
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer.
Gynecol Oncol;
108(1): 42-6, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17980406
20.
Pharmacokinetics of heated intraperitoneal oxaliplatin.
Cancer Chemother Pharmacol;
62(4): 679-83, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18084764